1Hamburg MA, Collins FS. The path Io personalized medicine[ J]. N Engl J Med, 2010, 363(4) :301-304. 被引量：1
2Chin L, Andersen JN, Futreal PA. Cancer genomivs: from discovely science to pqsmlalized medicine [ J]. Nat Med, 2011,17 ( 3 ) :297-303. 被引量：1
3Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine[ J]. N Engl J Med, 2012, 366(6) :489-491. 被引量：1
4Katsnelson A. Momentum grows to make ' personalized' medicine more ' precise' [ J]. Nat Med, 2013, 19 (3) :249. 被引量：1
5Collins FS, Varmus H. A new initiative on precision medicine [J]. N Engl J Med, 2015, 372(9) :793-795. 被引量：1
6Longo DL. Tumor heterogeneity and personalized medicine [ J ]. N Engl J Med, 2012, 366(10) :956-957. 被引量：1
7Burrell RA, McGranahan N, Bartek J, et al. The causes and consequences of genetic heterogeneity in cancer evolution [ J ]. Nature, 2013, 501 (7467) :338-345. 被引量：1
8Ogino S, Chan AT, Fuchs CS, et al. Molecular pathological epidemiology of colorectal neoplasia : an emergingtransdisciplinary and interdisciplinary field[ J]. Gut, 2011,60 (3) :397-411. 被引量：1
9Ogino S, Stampfer M. Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology [ J ]. J Natl Cancer Inst, 2010, 102 ( 6 ) :365-367. 被引量：1
10Curtin K, Samowitz WS, Wolff RK, et al. Somatic alterations, metabolizing genes and smoking in rectal cancer[ J ]. Int J Cancer, 2009, 125 ( 1 ) : 158-164. 被引量：1
